Login Register Cart 0
Generic placeholder image

Current Reviews in Clinical and Experimental Pharmacology

Editor-in-Chief

ISSN (Print): 2772-4328
ISSN (Online): 2772-4336

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Review Article

Chlorpheniramine, an Old Drug with New Potential Clinical Applications: A Comprehensive Review of the Literature

Author(s): Syed A.A. Rizvi, Gustavo Ferrer, Uzzam A. Khawaja and Marcos A. Sanchez-Gonzalez*

Volume 19, Issue 2, 2024

Published on: 22 August, 2022

Page: [137 - 145] Pages: 9

DOI: 10.2174/2772432817666220601162006

Price: $65

Abstract

Chlorpheniramine Maleate (CPM), also known as chlorphenamine, is a potent alkylamine first-generation H1 antihistamine that has been used since the 1950s. CPM is a widely popular drug commonly used to treat allergic conditions, given its antihistamine properties. Although mainly used in over-the-counter treatment for cough and colds, various studies discuss a wide range of CPM's clinical uses, such as treating asthma, plasma cell gingivitis, chronic urticaria, and depression, among others. This antihistamine is usually taken orally; however, intravenous, intramuscular, and subcutaneous routes have been documented. Intranasal routes of this drug have recently been explored, especially due to its antiviral properties against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Accordingly, given CPM's extensive medical and safety profile, the present review explores this versatile drug's current and potential clinical applications. Although it is widely used mainly for treating common colds and aforementioned allergic conditions, CPM can be used for other clinical indications. The repurposing of CPM for other clinical indications, such as COVID-19, needs to be further explored through more extensive studies.

Keywords: Chlorpheniramine, allergy, rhinitis, urticarial, viral infections, intranasal

« Previous Next »
Graphical Abstract

[1]
Rumore MM. Clinical pharmacokinetics of chlorpheniramine. Drug Intell Clin Pharm 1984; 18(9): 701-7.
[http://dx.doi.org/10.1177/106002808401800905] [PMID: 6383755]
[2]
Hall EJ, Hall GJ. Chlorpheniramine. In: Encyclopedia of ToxicologyElsevier: Amsterdam. 2014; pp. 923-4.
[http://dx.doi.org/10.1016/B978-0-12-386454-3.00711-9]
[3]
Hellbom E. Chlorpheniramine, Selective serotonin-reuptake inhibitors (SSRIs) and over-the-counter (OTC) treatment. Med Hypotheses 2006; 66(4): 689-90.
[http://dx.doi.org/10.1016/j.mehy.2005.12.006] [PMID: 16413139]
[4]
Xu W, Xia S, Pu J, et al. The antihistamine drugs carbinoxamine maleate and chlorpheniramine maleate exhibit potent antiviral activity against a broad spectrum of influenza viruses. Front Microbiol 2018; 9: 2643.
[http://dx.doi.org/10.3389/fmicb.2018.02643] [PMID: 30459739]
[5]
Woo T. Pharmacology of cough and cold medicines. J Pediatr Health Care 2008; 22(2): 73-9.
[http://dx.doi.org/10.1016/j.pedhc.2007.12.007]
[6]
Isbister GK, Prior F, Kilham HA. Restricting cough and cold medicines in children. J Paediatr Child Health 2012; 48(2): 91-8.
[http://dx.doi.org/10.1111/j.1440-1754.2010.01780.x] [PMID: 20598066]
[7]
Kar S, Krishnan A, Preetha K, Mohankar A. A review of antihistamines used during pregnancy. J Pharmacol Pharmacother 2012; 3(2): 105-8.
[http://dx.doi.org/10.4103/0976-500X.95503] [PMID: 22629082]
[8]
Slavin RG. Treating rhinitis in the older population: Special considerations. Allergy Asthma Clin Immunol 2009; 5(1): 9.
[http://dx.doi.org/10.1186/1710-1492-5-9] [PMID: 20016692]
[9]
Sanchez-Gonzalez M, Rizvi SA, Torres J, Ferrer G. A Randomized controlled pilot trial to test the efficacy of intranasal chlorpheniramine maleate with xylitol for the treatment of allergic rhinitis. Cureus 2021; 13(3): e14206.
[http://dx.doi.org/10.7759/cureus.14206] [PMID: 33816038]
[10]
Torres J, Go CC, Chohan F, Camacho L G, Sanchez-Gonzalez MA, Ferrer G. . Chlorpheniramine maleate nasal spray in COVID- 19 patients: Case series J Clin Exp Pharmacol 11(1): 275-6.
[11]
Serotonin | C10H12N2O Available from: https://pubchem.ncbi. nlm.nih.gov/compound/serotonin (Accessed on May 20, 2022).
[12]
Walsh GM. . Antihistamines (H1 receptor antagonists). In: Side Effects of Drugs Annual, Elsevier Science, 2012; 34: pp. 271-6.
[http://dx.doi.org/10.1016/B978-0-444-59499-0.00015-5]
[13]
Swanson-Biearman B. Chlorpheniramine. In: Encyclopedia of Toxicology Elsevier: Amsterdam. 2005; pp. 577-8.
[http://dx.doi.org/10.1016/B0-12-369400-0/00226-X]
[14]
Aronson JK. Chloroquine and hydroxychloroquine meyler’s side effects of drugs; Elsevier: Amsterdam. (16th ed.). 2006; pp. 722-30.
[http://dx.doi.org/10.1016/B0-44-451005-2/00710-5]
[15]
Kirkegaard J, Secher C, Borum P, Mygind N. Inhibition of histamine-induced nasal symptoms by the H1 antihistamine chlorpheniramine maleate: Demonstration of topical effect. Br J Dis Chest 1983; 77(2): 113-22.
[http://dx.doi.org/10.1016/0007-0971(83)90017-7] [PMID: 6347231]
[16]
Van Toor BS, Buchwald A, Stengele E, Trenk D, Gercek C, de Mey CM. Systemic bioavailability of nasally applied chlorphenamine maleate (0.4% nasal spray) relative to tablets administered perorally. Int J Clin Pharmacol Ther 2001; 39(4): 173-8.
[http://dx.doi.org/10.5414/CPP39173] [PMID: 11332874]
[17]
Kumar M, Upadhayay P, Shankar R, Joshi M, Bhatt S, Malik A. Chlorpheniramine maleate containing chitosan-based nanoparticle-loaded thermosensitive in situ gel for management in allergic rhinitis. Drug Deliv Transl Res 2019; 9(6): 1017-26.
[http://dx.doi.org/10.1007/s13346-019-00639-w] [PMID: 31049842]
[18]
Mandola A, Nozawa A, Eiwegger T. Histamine, histamine receptors, and anti-histamines in the context of allergic responses. LymphoSign Journal 2019; 6(2): 35-51.
[http://dx.doi.org/10.14785/lymphosign-2018-0016]
[19]
Thangam EB, Jemima EA, Singh H, et al. The role of histamine and histamine receptors in mast cell-mediated allergy and inflammation: The hunt for new therapeutic targets. Front Immunol 2018; 9(8): 1873.
[http://dx.doi.org/10.3389/fimmu.2018.01873] [PMID: 30150993]
[20]
Patel RH, Mohiuddin SS. Biochemistry, Histamine. StatPearls Publishing : Orlando, Florida 2021.
[21]
Baroody FM, Naclerio RM. Antiallergic effects of H1-receptor antagonistsAllergy 2000; 55 Suppl 6(64): 17-27.
[http://dx.doi.org/10.1034/j.1398-9995.2000.00803.x]
[22]
Chugh J, Yadav YR, Kulkarni HS, Maheshwari S. The effect of aerosolized chlorpheniramine maleate on exercise induced bron-chospasm and gas exchange in asthmatics. J Assoc Phys India 2020; 68(4): 21-5.
[PMID: 32610841]
[23]
Hasala H, Moilanen E, Janka-Junttila M, Giembycz MA, Kankaanranta H. First-generation antihistamines diphenhydramine and chlorpheniramine reverse cytokine-afforded eosinophil survival by enhancing apoptosis. Allergy Asthma Proc 2007; 28(1): 79-86.
[http://dx.doi.org/10.2500/aap.2007.28.2961] [PMID: 17390763]
[24]
Chang YL, Lin CS, Wang HW, Jian KR, Liu SC. Chlorpheniramine attenuates histamine-mediated aquaporin 5 downregulation in human nasal epithelial cells via suppression of NF-κB activation. Int J Med Sci 2017; 14(12): 1268-75.
[http://dx.doi.org/10.7150/ijms.21573] [PMID: 29104484]
[25]
Liu T, Zhang L, Joo D, Sun SC. NF-κB signaling in inflammation. Signal Transduct Target Ther 2017; 2: 17023.
[http://dx.doi.org/10.1038/sigtrans.2017.23] [PMID: 29158945]
[26]
Yuan H, Silberstein SD. Histamine and migraine. Headache 2018; 58(1): 184-93.
[http://dx.doi.org/10.1111/head.13164] [PMID: 28862769]
[27]
Blendea D, Mircioiu I, Sandulovici R, et al. Non-inferiority study concerning a new analgesic formulation versus an acetylsalicylic acid, acetaminophen and caffeine fixed combination in patients with headache. Ther Pharmacol Clin Toxicol 2011; 15(3): 190-6.
[28]
Voicu VA, Mircioiu I, Sandulovici R, et al. Chlorpheniramine potentiates the analgesic effect in migraine of usual caffeine, acetaminophen, and acetylsalicylic acid combination. Front Pharmacol 2017; 8: 758.
[http://dx.doi.org/10.3389/fphar.2017.00758] [PMID: 29114224]
[29]
Fang SY, Druce HM, Baraniuk JN. Anticholinergic properties of brompheniramine, chlorpheniramine, and atropine in human nasal mucosa in vitro. Am J Rhinol 1998; 12(2): 131-3.
[http://dx.doi.org/10.2500/105065898781390271] [PMID: 9578932]
[30]
D’Agostino RB Sr, Weintraub M, Russell HK, et al. The effectiveness of antihistamines in reducing the severity of runny nose and sneezing: A meta-analysis. Clin Pharmacol Ther 1998; 64(6): 579-96.
[http://dx.doi.org/10.1016/S0009-9236(98)90049-2] [PMID: 9871423]
[31]
Huh H, Lee SW, Cho JE, Kim HC. Effect of chlorpheniramine administration on postoperative catheter-related bladder discomfort in patients undergoing transurethral excision of bladder tumor: A prospective randomized study. J Anesth 2021; 35(5): 646-53.
[http://dx.doi.org/10.1007/s00540-021-02970-4] [PMID: 34245368]
[32]
Gray SL, Anderson ML, Dublin S, et al. Cumulative use of strong anticholinergics and incident dementia: A prospective cohort study. JAMA Intern Med 2015; 175(3): 401-7.
[http://dx.doi.org/10.1001/jamainternmed.2014.7663] [PMID: 25621434]
[33]
Orzechowski RF, Currie DS, Valancius CA. Comparative anticholinergic activities of 10 histamine H1 receptor antagonists in two functional models. Eur J Pharmacol 2005; 506(3): 257-64.
[http://dx.doi.org/10.1016/j.ejphar.2004.11.006] [PMID: 15627436]
[34]
Doyle WJ, McBride TP, Skoner DP, Maddern BR, Gwaltney JM Jr, Uhrin M. A double-blind, placebo-controlled clinical trial of the effect of chlorpheniramine on the response of the nasal airway, middle ear and eustachian tube to provocative rhinovirus challenge. Pediatr Infect Dis J 1988; 7(3): 229-38.
[http://dx.doi.org/10.1097/00006454-198803000-00033] [PMID: 3282216]
[35]
Gwaltney JM Jr, Druce HM. Efficacy of brompheniramine maleate for the treatment of rhinovirus colds. Clin Infect Dis 1997; 25(5): 1188-94.
[http://dx.doi.org/10.1086/516105] [PMID: 9402380]
[36]
Qu C, Fuhler GM, Pan Y. Could histamine H1 receptor antagonists be used for treating COVID-19? Int J Mol Sci 2021; 22(11): 5672.
[http://dx.doi.org/10.3390/ijms22115672] [PMID: 34073529]
[37]
Roumestan C, Henriquet C, Gougat C, et al. Histamine H1-receptor antagonists inhibit nuclear factor-kappaB and activator protein-1 activities via H1-receptor-dependent and -independent mechanisms. Clin Exp Allergy 2008; 38(6): 947-56.
[http://dx.doi.org/10.1111/j.1365-2222.2008.02990.x] [PMID: 18498541]
[38]
Westover JB, Ferrer G, Vazquez H, Bethencourt-Mirabal A, Go CC. In vitro virucidal effect of intranasally delivered chlorpheniramine maleate compound against severe acute respiratory syndrome coronavirus 2. Cureus 2020; 12(9): e10501.
[http://dx.doi.org/10.7759/cureus.10501] [PMID: 32963923]
[39]
Mostafa A, Kandeil A, Elshaier YAMM, et al. FDA-approved drugs with potent in vitro antiviral activity against severe acute respiratory syndrome coronavirus 2. Pharmaceuticals 2020; 13(12): 1-24.
[http://dx.doi.org/10.3390/ph13120443] [PMID: 33291642]
[40]
Black SD. Molecular modeling and preliminary clinical data suggesting antiviral activity for chlorpheniramine (chlorphenamine) against COVID-19. Cureus 2022; 14(1): e20980.
[http://dx.doi.org/10.7759/cureus.20980]
[41]
Yang L, Pei RJ, Li H, et al. Identification of SARS-CoV-2 entry inhibitors among already approved drugs. Acta Pharmacol Sin 2021; 42(8): 1347-53.
[http://dx.doi.org/10.1038/s41401-020-00556-6] [PMID: 33116249]
[42]
Reznikov LR, Norris MH, Vashisht R, et al. Identification of antiviral antihistamines for COVID-19 repurposing. Biochem Biophys Res Commun 2021; 538: 173-9.
[http://dx.doi.org/10.1016/j.bbrc.2020.11.095] [PMID: 33309272]
[43]
Gwaltney JM Jr, Winther B, Patrie JT, Hendley JO. Combined antiviral-antimediator treatment for the common cold. J Infect Dis 2002; 186(2): 147-54.
[http://dx.doi.org/10.1086/341455] [PMID: 12134249]
[44]
Nakornchai S, Konthiang P. Potentiation of antimalarial drug action by chlorpheniramine against multidrug-resistant Plasmodium falciparum in vitro. Parasitol Int 2006; 55(3): 195-9.
[http://dx.doi.org/10.1016/j.parint.2005.11.058] [PMID: 16750932]
[45]
Pereira MR, Henrich PP, Sidhu ABS, et al. In vivo and in vitro antimalarial properties of azithromycin-chloroquine combinations that include the resistance reversal agent amlodipine. Antimicrob Agents Chemother 2011; 55(7): 3115-24.
[http://dx.doi.org/10.1128/AAC.01566-10] [PMID: 21464242]
[46]
Deane KJ, Summers RL, Lehane AM, Martin RE, Barrow RA. Chlorpheniramine analogues reverse chloroquine resistance in plasmodium falciparum by inhibiting PfCRT. ACS Med Chem Lett 2014; 5(5): 576-81.
[http://dx.doi.org/10.1021/ml5000228] [PMID: 24900883]
[47]
Chu A, Wadhwa R. Selective serotonin reuptake inhibitors.StatPearls Publishing Orlando, Florida, 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554406/
[48]
Gammoh O, Mayyas F, Darwish EF. Chlorpheniramine and escitalopram: Similar antidepressant and nitric oxide lowering roles in a mouse model of anxiety. Biomed Rep 2017; 6(6): 675-80.
[http://dx.doi.org/10.3892/br.2017.901] [PMID: 28584640]
[49]
Parisi GF, Leonardi S, Ciprandi G, et al. Antihistamines in children and adolescents: A practical update. Allergol Immunopathol 2020; 48(6): 753-62.
[http://dx.doi.org/10.1016/j.aller.2020.02.005] [PMID: 32448753]
[50]
Yanai K, Zhang D, Tashiro M, et al. Positron emission tomography evaluation of sedative properties of antihistamines. Expert Opin Drug Saf 2011; 10(4): 613-22.
[http://dx.doi.org/10.1517/14740338.2011.562889] [PMID: 21521134]
[51]
Malamed SF, Orr DL. Preparation. In: Medical Emergencies in the Dental Office. Elsevier: Amsterdam, 2015; 62: p. 112.
[http://dx.doi.org/10.1016/B978-0-323-17122-9.00003-2]
[52]
Ricci AR, Settipane RJ, Goldstein BM, Kalliel JN, Settipane GA. The effect of chlorpheniramine on asthma. Allergy proc 1990; 11(5): 229-33.
[http://dx.doi.org/10.2500/108854190778879873]
[53]
Akhouri S, House SA. Allergic Rhinitis (Nursing). In: StatPearls Internet]. Treasure Island, (FL): StatPearls Publishing 2022.
[54]
Meltzer EO, Berman GD, Corren J, et al. Addition of ibuprofen to pseudoephedrine and chlorpheniramine in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2004; 93(5): 452-9.
[http://dx.doi.org/10.1016/S1081-1206(10)61412-3]
[55]
Sur DKC, Plesa ML. Treatment of allergic rhinitis. Am Fam Physician 2015; 92(11): 985-92.
[http://dx.doi.org/10.5005/jp/books/12714_15] [PMID: 26760413]
[56]
Sur DK, Scandale S. Treatment of allergic rhinitis. Am Fam Physician 2010; 81(12): 1440-6.
[PMID: 20540482]
[57]
Bleehen SS, Thomas SE, Greaves MW, et al. Cimetidine and chlorpheniramine in the treatment of chronic idiopathic urticaria: A multi-centre randomized double-blind study. Br J Dermatol 1987; 117(1): 81-8.
[http://dx.doi.org/10.1111/j.1365-2133.1987.tb04095.x] [PMID: 3307890]
[58]
Buckey JC, Alvarenga D, Cole B, Rigas JR. Chlorpheniramine for motion sickness. J Vestib Res 2004; 14(1): 53-61.
[59]
Janam P, Nayar BR, Mohan R, Suchitra A. Plasma cell gingivitis associated with cheilitis: A diagnostic dilemma! J Indian Soc Periodontol 2012; 16(1): 115-9.
[http://dx.doi.org/10.4103/0972-124X.94618] [PMID: 22628976]
[60]
Ranganathan AT, Chandran CR, Prabhakar P, Lakshmiganthan M, Parthasaradhi T. Plasma cell gingivitis: Treatment with chlorpheniramine maleate. Int J Periodont Restor Dent 2015; 35(3): 411-3.
[http://dx.doi.org/10.11607/prd.2111] [PMID: 25909529]
[61]
Falade CO, Michael SO, Oduola AMJ. Enhanced efficacy of amodiaquine and chlorpheniramine combination over amodiaquine alone in the treatment of acute uncomplicated Plasmodium falciparum malaria in children. Med Princ Pract 2008; 17(3): 197-201.
[http://dx.doi.org/10.1159/000117792] [PMID: 18408387]
[62]
Gaffey MJ, Gwaltney JM Jr, Sastre A, Dressler WE, Sorrentino JV, Hayden FG. Intranasally and orally administered antihistamine treatment of experimental rhinovirus colds. Am Rev Respir Dis 1987; 136(3): 556-60.
[http://dx.doi.org/10.1164/ajrccm/136.3.556] [PMID: 3307567]
[63]
De Sutter AIM, van Driel ML, Kumar AA, Lesslar O, Skrt A. Oral antihistamine-decongestant-analgesic combinations for the common cold. Cochrane Database Syst Rev 2012; 86(2): CD004976.
[http://dx.doi.org/10.1002/14651858.CD004976.pub3] [PMID: 22336807]
[64]
Morán BJI, Alvarenga BJA, Homma S, Suzuki K, Fremont-Smith P, Villar Gómez de Las Heras K. Antihistamines and azithromycin as a treatment for COVID-19 on primary health care - A retrospective observational study in elderly patients. Pulm Pharmacol Ther 2021; 67: 101989.
[http://dx.doi.org/10.1016/j.pupt.2021.101989] [PMID: 33465426]
[65]
Kim HJ, Kim DK, Kim HY, Kim JK, Choi SW. Risk factors of emergence agitation in adults undergoing general anesthesia for nasal surgery. Clin Exp Otorhinolaryngol 2015; 8(1): 46-51.
[http://dx.doi.org/10.3342/ceo.2015.8.1.46] [PMID: 25729495]
[66]
Abdelrahman TN, Kasem AA. Role of preemptive chlorpheniramine maleate in reducing postoperative agitation after Functional Endoscopic Sinus Surgeries (FESS). Ain-Shams J Anesthesiol 2020; 12(1): 26.
[http://dx.doi.org/10.1186/s42077-020-00074-x]
[67]
Makrilia N, Syrigou E, Kaklamanos I, Manolopoulos L, Saif MW. Hypersensitivity reactions associated with platinum antineoplastic agents: A systematic review. Met Based Drugs 2010; 2010: Article ID: 207084.
[http://dx.doi.org/10.1155/2010/207084] [PMID: 20886011]
[68]
Harada T, Doi M, Yamada Y, Akase T. Evaluation of short-time premedication with d-chlorpheniramine maleate injection for paclitaxel-induced hypersensitivity reaction. Gan to kagaku ryoho. Cancer Chemother 2008; 35(8): 1347-51.
[PMID: 18701846]
[69]
Ikegawa K, Suzuki S, Nomura H, et al. Retrospective analysis of premedication, glucocorticosteroids, and H1-antihistamines for preventing infusion reactions associated with cetuximab treatment of patients with head and neck cancer. J Int Med Res 2017; 45(4): 1378-85.
[http://dx.doi.org/10.1177/0300060517713531] [PMID: 28606015]
[70]
Komatsubara K, Miyoshi K, Kogure Y, Matsuhisa T, Eguchi H. Administration of premedication with fexofenadine for paclitaxel-induced hypersensitive reactions in breast cancer patients complicated with closed-angle glaucoma. Gan to kagaku ryoho. Cancer Chemother 2010; 37(1): 107-10.
[PMID: 20087041]
[71]
Effect of the antihistamine injection to prevent paradoxical reaction during sedative endoscopy. ClinicalTrialsgov Available from: https://clinicaltrials.gov/ct2/show/NCT03940391?term=chlorpheniramine&recrs=abdf&draw=2&rank=4 (Accessed on May 21, 2022).
[72]
The Safety and Effectiveness of Local Injection of Antihistamines in Treatment of Inflammatory Skin Diseases ClinicalTrialsgov Available from: https://clinicaltrials.gov/ct2/show/NCT04937101?term=chlorpheniramine&recrs=abdf&draw=2&rank=3 (Accessed on May 21, 2022).
[73]
Chlorpheniramine maleate nasal spray for chronic rhinitis. ClinicalTrialsgov Available from: https://clinicaltrials.gov/ct2/show/NCT04790487?term=chlorpheniramine&recrs=abdf&draw=2&rank=2 (Accessed on May 21, 2022).
[74]
Efficacy of placebo versus chlorpheniramine for the prevention of allergic transfusion reactions. ClinicalTrialsgov Available from: https://clinicaltrials.gov/ct2/show/NCT04688736?term=chlorpheniramine&recrs=abdf&draw=2&rank=1 (Accessed on May 21, 2022).

Rights & Permissions Print Cite
Article Metrics
3
© 2024 Bentham Science Publishers | Privacy Policy